147 related articles for article (PubMed ID: 24376663)
1. Colorectal cancer risk reduction following macrogol exposure: a cohort and nested case control study in the UK.
Charlton RA; Snowball JM; Bloomfield K; de Vries CS
PLoS One; 2013; 8(12):e83203. PubMed ID: 24376663
[TBL] [Abstract][Full Text] [Related]
2. Laxative type in relation to colorectal cancer risk.
Citronberg JS; Hardikar S; Phipps A; Figueiredo JC; Newcomb P
Ann Epidemiol; 2018 Oct; 28(10):739-741. PubMed ID: 30150160
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of macrogol 3350 compared to lactulose in the treatment of adults suffering from chronic constipation in the UK.
Taylor RR; Guest JF
Aliment Pharmacol Ther; 2010 Jan; 31(2):302-12. PubMed ID: 19886948
[TBL] [Abstract][Full Text] [Related]
4. New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case-control study in UK general practice.
García Rodríguez LA; Soriano-Gabarró M; Bromley S; Lanas A; Cea Soriano L
BMC Cancer; 2017 Sep; 17(1):637. PubMed ID: 28882113
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of the effect of bowel movement frequency, constipation, and laxative use on colorectal cancer risk.
Citronberg J; Kantor ED; Potter JD; White E
Am J Gastroenterol; 2014 Oct; 109(10):1640-9. PubMed ID: 25223576
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK.
Guest JF; Clegg JP; Helter MT
Curr Med Res Opin; 2008 Jul; 24(7):1841-52. PubMed ID: 18558017
[TBL] [Abstract][Full Text] [Related]
7. Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk.
Boursi B; Haynes K; Mamtani R; Yang YX
J Natl Cancer Inst; 2015 Jun; 107(6):djv084. PubMed ID: 25855726
[TBL] [Abstract][Full Text] [Related]
8. Exposure to colorectal examinations before a colorectal cancer diagnosis: a case-control study.
Mulder SA; van Soest EM; Dieleman JP; van Rossum LG; Ouwendijk RJ; van Leerdam ME; Kuipers EJ
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):437-43. PubMed ID: 19952765
[TBL] [Abstract][Full Text] [Related]
9. Height as an independent anthropomorphic risk factor for colorectal cancer.
Boursi B; Haynes K; Mamtani R; Yang YX
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1422-7. PubMed ID: 25264984
[TBL] [Abstract][Full Text] [Related]
10. Oral antibiotic use and early-onset colorectal cancer: findings from a case-control study using a national clinical database.
McDowell R; Perrott S; Murchie P; Cardwell C; Hughes C; Samuel L
Br J Cancer; 2022 Apr; 126(6):957-967. PubMed ID: 34921228
[TBL] [Abstract][Full Text] [Related]
11. The LUCK study: Laxative Usage in patients with GP-diagnosed Constipation in the UK, within the general population and in pregnancy. An epidemiological study using the General Practice Research Database (GPRD).
Shafe AC; Lee S; Dalrymple JS; Whorwell PJ
Therap Adv Gastroenterol; 2011 Nov; 4(6):343-63. PubMed ID: 22043228
[TBL] [Abstract][Full Text] [Related]
12. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study.
Doubeni CA; Weinmann S; Adams K; Kamineni A; Buist DS; Ash AS; Rutter CM; Doria-Rose VP; Corley DA; Greenlee RT; Chubak J; Williams A; Kroll-Desrosiers AR; Johnson E; Webster J; Richert-Boe K; Levin TR; Fletcher RH; Weiss NS
Ann Intern Med; 2013 Mar; 158(5 Pt 1):312-20. PubMed ID: 23460054
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.
Makar GA; Holmes JH; Yang YX
J Natl Cancer Inst; 2014 Feb; 106(2):djt374. PubMed ID: 24431411
[TBL] [Abstract][Full Text] [Related]
14. The role of statins for primary prevention in non-elderly colorectal cancer patients.
Sehdev A; Shih YC; Huo D; Vekhter B; Lyttle C; Polite B
Anticancer Res; 2014 Sep; 34(9):5043-50. PubMed ID: 25202089
[TBL] [Abstract][Full Text] [Related]
15. Constipation--modern laxative therapy.
Klaschik E; Nauck F; Ostgathe C
Support Care Cancer; 2003 Nov; 11(11):679-85. PubMed ID: 14505158
[TBL] [Abstract][Full Text] [Related]
16. Impact of antibiotic exposure on the risk of colorectal cancer.
Boursi B; Haynes K; Mamtani R; Yang YX
Pharmacoepidemiol Drug Saf; 2015 May; 24(5):534-42. PubMed ID: 25808540
[TBL] [Abstract][Full Text] [Related]
17. Pernicious anemia and colorectal cancer risk - A nested case-control study.
Boursi B; Mamtani R; Haynes K; Yang YX
Dig Liver Dis; 2016 Nov; 48(11):1386-1390. PubMed ID: 27481584
[TBL] [Abstract][Full Text] [Related]
18. Does adherence to the World Cancer Research Fund/American Institute of Cancer Research cancer prevention guidelines reduce risk of colorectal cancer in the UK Women's Cohort Study?
Jones P; Cade JE; Evans CEL; Hancock N; Greenwood DC
Br J Nutr; 2018 Feb; 119(3):340-348. PubMed ID: 29352814
[TBL] [Abstract][Full Text] [Related]
19. Chronic statin therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sarkar M; Lewis JD
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):869-76. PubMed ID: 18412290
[TBL] [Abstract][Full Text] [Related]
20. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
